Company Overview
Company Type: Private Company
Website: www.itrlab.com
Number of Employees: 200
Year Founded: 1989
Total Amount Raised (CAD mm)†: -
Total Rounds of Funding**:-
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
ITR Laboratories Canada, Inc., a pre-clinical research organization, provides non-clinical toxicology services for biotechnology and pharmaceutical industries in North America and Europe. It offers mammalian toxicology services, including general toxicology, infusion, inhalation, and carcinogenicity; pathology services, including histopathology laboratory; and safety pharmacology, pharmacy, clinical pathology, and quality assurance services. The company also provides analytical and bio-analysis services, such as drug stability and impurity tests, analytical method development, test article (TA) formulations analysis, aerosolized drugs analysis, and LC-MS-MS and/or HPLC bio-analysis of TA or drug metabolites in urine, plasma, or serum. ITR Laboratories Canada, Inc. has a strategic alliance with Altasciences. The company was founded in 1989 and is based in Montreal, Canada.


Financial Information (Currency: CAD, in mm)
Total Revenue
 62.5
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
 200
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
Name
Title
Yamanouchi, Kumi
President
Bier, Colin B.
Founder
Bain, Ginette
Senior Vice President


Primary Industry Classification
Life Sciences Tools and Services


Primary Office Location
19601 Clark Graham Baie d'Urfe | Montreal, QC | H9X 3T1 | Canada
Phone: 514-457-7400   Fax: 514-457-7303


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Last 5 Key Developments
Date
Event Type
Headline
Mar-20-2023
Company Conference Presentations
ITR Laboratories Canada, Inc. Presents at BIO-Europe Spring 2023, Mar-20-2023
Mar-07-2017
Executive/Board Changes - Other
Stephen Groom Joins ITR Laboratories Canada Inc. as Senior Veterinary Pathologist
Jan-17-2017
Executive/Board Changes - Other
ITR Laboratories Canada Inc. Appoints Mark T. Crane as Vice President of Business Development
Nov-02-2015
Company Conference Presentations
ITR Laboratories Canada, Inc. Presents at BIO-Europe 2015, Nov-02-2015
Mar-09-2015
Company Conference Presentations
ITR Laboratories Canada, Inc. Presents at BIO-Europe Spring 2015, Mar-09-2015


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 14, 2023 08:24 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
21
GlobalData

Dec 16, 2022 02:44 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
24
GlobalData

Sep 20, 2022 07:21 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
24
GlobalData

Jun 18, 2022 03:27 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
24
GlobalData

Mar 15, 2022 04:52 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
24
GlobalData

Dec 14, 2021 01:28 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
22
GlobalData

Sep 14, 2021 06:50 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
17
GlobalData

Jun 14, 2021 01:40 PM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
17
GlobalData

Dec 10, 2020 02:31 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
19
GlobalData

Sep 14, 2020 02:16 AM
ITR Laboratories Canada, Inc.
ITR Laboratories Canada Inc
Reports
19


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.


Upcoming Events
Date/Time
Type
Nov-12-2023
Conferences
* Future Events are subject to change.

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Yamanouchi, Kumi
President
514-457-7400
514-457-7303
-
Bier, Colin B.
Founder
514-457-7400
514-457-7303

Bain, Ginette
Senior Vice President
514-457-7400
514-457-7303
-
* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
